Recruiting Venetoclax for the Treatment of Patients With Relapsed Hairy Cell Leukemia NCT06311227 Conditions Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more Locations City of Hope Comprehensive Cancer Center — Duarte, California, United States City of Hope at Irvine Lennar — Irvine, California, United States UM Sylvester Comprehensive Cancer Center at Aventura — Aventura, Florida, United States UM Sylvester Comprehensive Cancer Center at Coral Gables — Coral Gables, Florida, United States View all 21 locations View more locations Show fewer locations Loading locations... View Trial Details
Active, Not Recruiting Ibrutinib in Treating Patients With Relapsed Hairy Cell Leukemia NCT01841723 Conditions Hairy Cell Leukemia, Hairy Cell Leukemia Variant, Hematologic Diseases, +11 more Locations National Institutes of Health Clinical Center — Bethesda, Maryland, United States Wayne State University/Karmanos Cancer Institute — Detroit, Michigan, United States Mayo Clinic in Rochester — Rochester, Minnesota, United States Ohio State University Comprehensive Cancer Center — Columbus, Ohio, United States View more locations Show fewer locations Loading locations... View Trial Details
